Eliem Therapeutics Inc

NASDAQ ELYM

Data sourced from

and

Download Data

Eliem Therapeutics Inc Total Investments for the year ending December 31, 2023

Eliem Therapeutics Inc Total Investments is NA for the year ending December 31, 2023. Total Investments is the sum of short-term and long-term investments held by a company.

Eliem Therapeutics Inc Total Investments for the year ending December 31, 2022 was USD 79.98 M, a -30.13% change year over year.
Eliem Therapeutics Inc Total Investments for the year ending December 31, 2021 was USD 114.48 M, a 0.00% change year over year.
Eliem Therapeutics Inc Total Investments for the year ending December 31, 2020 was USD 0.00.

NASDAQ: ELYM

Eliem Therapeutics Inc

CEO	Mr. Robert W. Azelby M.B.A.
IPO Date	Aug. 10, 2021
Location	United States
Headquarters	23515 NE Novelty Hill Road, Redmond, WA, United States, 98053
Employees	9
Sector	Healthcare
Industry	Biotechnology

Description

Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems. The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.

Key trends